[{"address1": "18 Hasivim Street", "city": "Petah Tikva", "zip": "4959376", "country": "Israel", "phone": "972 7 4719 5700", "website": "https://www.polypid.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.", "fullTimeEmployees": 59, "companyOfficers": [{"maxAge": 1, "name": "Ms. Dikla  Czaczkes Akselbrad", "age": 50, "title": "CEO & Director", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 347883, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jonny  Missulawin", "age": 36, "title": "Chief Financial Officer", "yearBorn": 1987, "fiscalYear": 2023, "totalPay": 186960, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Dalit  Hazan", "age": 52, "title": "Deputy CEO and Executive VP of R&D, Clinical & Regulatory Affairs", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 272381, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ori  Warshavsky", "age": 45, "title": "Chief Operating Officer - US", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 340889, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maria  Rubin", "title": "Vice President of Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tal  Vilnai", "title": "General Counsel & Corporate Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rivi  Lev-ari", "title": "Vice President of Human Resource", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jean-Marc  Hagai Pharm.D.", "title": "Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 3.47, "open": 3.55, "dayLow": 3.43, "dayHigh": 3.55, "regularMarketPreviousClose": 3.47, "regularMarketOpen": 3.55, "regularMarketDayLow": 3.43, "regularMarketDayHigh": 3.55, "beta": 1.319, "forwardPE": -1.1582491, "volume": 3671, "regularMarketVolume": 3671, "averageVolume": 6838, "averageVolume10days": 5880, "averageDailyVolume10Day": 5880, "marketCap": 16789642, "fiftyTwoWeekLow": 2.95, "fiftyTwoWeekHigh": 9.3, "fiftyDayAverage": 3.66506, "twoHundredDayAverage": 4.714895, "currency": "USD", "enterpriseValue": 18423052, "floatShares": 1429101, "sharesOutstanding": 4797250, "sharesShort": 4195, "sharesShortPriorMonth": 2668, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.00090000004, "heldPercentInsiders": 0.20517999, "heldPercentInstitutions": 0.32011002, "shortRatio": 0.59, "shortPercentOfFloat": 0.0011999999, "bookValue": 0.334, "priceToBook": 10.299401, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -24702000, "trailingEps": -8.76, "forwardEps": -2.97, "enterpriseToEbitda": -0.84, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "PYPD", "underlyingSymbol": "PYPD", "shortName": "PolyPid Ltd.", "longName": "PolyPid Ltd.", "firstTradeDateEpochUtc": 1593178200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "072b5519-59e2-39e3-ab26-dacec9b36f7c", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.44, "recommendationMean": 2.3, "recommendationKey": "buy", "totalCash": 9347000, "totalCashPerShare": 1.948, "ebitda": -21945000, "totalDebt": 11031000, "quickRatio": 0.909, "currentRatio": 0.951, "debtToEquity": 689.007, "returnOnAssets": -0.64646006, "returnOnEquity": -4.96622, "freeCashflow": -9818500, "operatingCashflow": -17449000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]